LIFE Study: Entresto TM in Advanced Heart Failure | Clinical Research Studies Listing

Recruiting

18 years - 100 years

All

Phase 3

20 participants needed

1 Location

Brief description of study

This study aims to understand the benefits/risks of Entresto in NYHA III-IV patients.

Detailed description of study

Follow up visits include taking study drug (Entresto vs Valsartan), blood work, physical exam, questionnaires, 6 min walk tests, and medication review.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions: Entresto,heart failure,end stage,blood pressure,heart disease,ejection fraction,cardiology,heart
Age: 18 years - 100 years
Gender: All

Updated on 19 Feb 2024. Study ID: 825912

Find a site

Your Information has been sent successfully.

Message sent successfully.

We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.

If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.

Send a message

Enter your contact details to connect with study team

First name*

Last name*

Email*

Phone number*

Preferred way of contact

Race

Ethnicity

Are you Healthy Volunteer

Other language

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).